Literature DB >> 21450819

Two distinct conformations of a rinderpest virus epitope presented by bovine major histocompatibility complex class I N*01801: a host strategy to present featured peptides.

Xin Li1, Jun Liu, Jianxun Qi, Feng Gao, Qirun Li, Xiaoying Li, Nianzhi Zhang, Chun Xia, George F Gao.   

Abstract

The presentation of viral peptide epitopes to host cytotoxic T lymphocytes (CTLs) is crucial for adaptive cellular immunity to clear the virus infection, especially for some chronic viral infections. Indeed, hosts have developed effective strategies to achieve this goal. The ideal scenario would be that the peptide epitopes stimulate a broad spectrum of CTL responses with diversified T-cell receptor (TCR) usage (the TCR repertoire). It is believed that a diversified TCR repertoire requires a "featured" peptide to be presented by the host major histocompatibility complex (MHC). A featured peptide can be processed and presented in a number of ways. Here, using the X-ray diffraction method, the crystal structures of an antigenic peptide derived from rinderpest virus presented by bovine MHC class I N*01801 (BoLA-A11) have been solved, and two distinct conformations of the presented peptide are clearly displayed. A detailed analysis of the structure and comparative sequences revealed that the polymorphic amino acid isoleucine 73 (Ile73) is extremely flexible, allowing the MHC groove to adopt different conformations to accommodate the rinderpest virus peptide. This makes the peptide more featured by exposing different amino acids for T-cell recognition. The crystal structures also demonstrated that the N*01801 molecule has an unusually large A pocket, resulting in the special conformation of the P1 residue at the N terminus of the peptide. We propose that this strategy of host peptide presentation might be beneficial for creating a diversified TCR repertoire, which is important for a more-effective CTL response.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21450819      PMCID: PMC3126294          DOI: 10.1128/JVI.00030-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  63 in total

1.  Functional avidity maturation of CD8(+) T cells without selection of higher affinity TCR.

Authors:  M K Slifka; J L Whitton
Journal:  Nat Immunol       Date:  2001-08       Impact factor: 25.606

2.  Producing nature's gene-chips: the generation of peptides for display by MHC class I molecules.

Authors:  Nilabh Shastri; Susan Schwab; Thomas Serwold
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

3.  Zooming in on the hydrophobic ridge of H-2D(b): implications for the conformational variability of bound peptides.

Authors:  C Ciatto; A C Tissot; M Tschopp; G Capitani; F Pecorari; A Plückthun; M G Grütter
Journal:  J Mol Biol       Date:  2001-10-05       Impact factor: 5.469

4.  Nonstandard peptide binding revealed by crystal structures of HLA-B*5101 complexed with HIV immunodominant epitopes.

Authors:  K Maenaka; T Maenaka; H Tomiyama; M Takiguchi; D I Stuart; E Y Jones
Journal:  J Immunol       Date:  2000-09-15       Impact factor: 5.422

5.  Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense.

Authors:  Ilhem Messaoudi; Jose A Guevara Patiño; Ruben Dyall; Joël LeMaoult; Janko Nikolich-Zugich
Journal:  Science       Date:  2002-11-29       Impact factor: 47.728

6.  PHENIX: building new software for automated crystallographic structure determination.

Authors:  Paul D Adams; Ralf W Grosse-Kunstleve; Li Wei Hung; Thomas R Ioerger; Airlie J McCoy; Nigel W Moriarty; Randy J Read; James C Sacchettini; Nicholas K Sauter; Thomas C Terwilliger
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2002-10-21

7.  Evolution of major histocompatibility complex class I genes in Cetartiodactyls.

Authors:  Edward C Holmes; Ann F C Roberts; Karen A Staines; Shirley A Ellis
Journal:  Immunogenetics       Date:  2003-05-17       Impact factor: 2.846

8.  Crystal structures of two closely related but antigenically distinct HLA-A2/melanocyte-melanoma tumor-antigen peptide complexes.

Authors:  P Sliz; O Michielin; J C Cerottini; I Luescher; P Romero; M Karplus; D C Wiley
Journal:  J Immunol       Date:  2001-09-15       Impact factor: 5.422

9.  Bovine lymphocyte antigen-A11--specific peptide motif as a means to identify cytotoxic T-lymphocyte epitopes of bovine herpesvirus 1.

Authors:  N R Hegde; M S Deshpande; D L Godson; L A Babiuk; S Srikumaran
Journal:  Viral Immunol       Date:  1999       Impact factor: 2.257

Review 10.  Cattle MHC: evolution in action?

Authors:  S A Ellis; K T Ballingall
Journal:  Immunol Rev       Date:  1999-02       Impact factor: 12.988

View more
  24 in total

1.  Expression, refolding and preliminary X-ray crystallographic analysis of equine MHC class I molecule complexed with an EIAV-Env CTL epitope.

Authors:  Shugang Yao; Jianxun Qi; Jun Liu; Rong Chen; Xiaocheng Pan; Xiaoying Li; Feng Gao; Chun Xia
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-12-24

2.  Diverse peptide presentation of rhesus macaque major histocompatibility complex class I Mamu-A 02 revealed by two peptide complex structures and insights into immune escape of simian immunodeficiency virus.

Authors:  Jun Liu; Lianpan Dai; Jianxun Qi; Feng Gao; Youjun Feng; Wenjun Liu; Jinghua Yan; George F Gao
Journal:  J Virol       Date:  2011-05-11       Impact factor: 5.103

3.  A Glimpse of the Peptide Profile Presentation by Xenopus laevis MHC Class I: Crystal Structure of pXela-UAA Reveals a Distinct Peptide-Binding Groove.

Authors:  Lizhen Ma; Nianzhi Zhang; Zehui Qu; Ruiying Liang; Lijie Zhang; Bing Zhang; Geng Meng; Johannes M Dijkstra; Shen Li; Max Chun Xia
Journal:  J Immunol       Date:  2019-11-27       Impact factor: 5.422

4.  Crystal structure of the giant panda MHC class I complex: First insights into the viral peptide presentation profile in the bear family.

Authors:  Hongyu Yuan; Lizhen Ma; Lijie Zhang; Xiaoying Li; Chun Xia
Journal:  Protein Sci       Date:  2020-10-30       Impact factor: 6.725

5.  Characterization of binding specificities of bovine leucocyte class I molecules: impacts for rational epitope discovery.

Authors:  Andreas M Hansen; Michael Rasmussen; Nicholas Svitek; Mikkel Harndahl; William T Golde; John Barlow; Vishvanath Nene; Søren Buus; Morten Nielsen
Journal:  Immunogenetics       Date:  2014-09-04       Impact factor: 2.846

6.  Structural and Biochemical Analyses of Swine Major Histocompatibility Complex Class I Complexes and Prediction of the Epitope Map of Important Influenza A Virus Strains.

Authors:  Shuhua Fan; Yanan Wu; Song Wang; Zhenbao Wang; Bo Jiang; Yanjie Liu; Ruiying Liang; Wenzhong Zhou; Nianzhi Zhang; Chun Xia
Journal:  J Virol       Date:  2016-07-11       Impact factor: 5.103

7.  Cross-allele cytotoxic T lymphocyte responses against 2009 pandemic H1N1 influenza A virus among HLA-A24 and HLA-A3 supertype-positive individuals.

Authors:  Jun Liu; Shihong Zhang; Shuguang Tan; Yong Yi; Bin Wu; Bin Cao; Fengcai Zhu; Chen Wang; Hua Wang; Jianxun Qi; George F Gao
Journal:  J Virol       Date:  2012-09-26       Impact factor: 5.103

8.  Crystallization and preliminary X-ray diffraction analysis of the two distinct types of zebrafish β2-microglobulin.

Authors:  Zhaosan Chen; Nianzhi Zhang; Shuangshuang Lu; Mansoor Tariq; Junya Wang; Chun Xia
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-05-22       Impact factor: 1.056

9.  Dynamics of free versus complexed β2-microglobulin and the evolution of interfaces in MHC class I molecules.

Authors:  Chee-Seng Hee; Monika Beerbaum; Bernhard Loll; Martin Ballaschk; Peter Schmieder; Barbara Uchanska-Ziegler; Andreas Ziegler
Journal:  Immunogenetics       Date:  2012-12-11       Impact factor: 2.846

10.  Structures of the MHC-I molecule BF2*1501 disclose the preferred presentation of an H5N1 virus-derived epitope.

Authors:  Xiaoying Li; Lijie Zhang; Yanjie Liu; Lizhen Ma; Nianzhi Zhang; Chun Xia
Journal:  J Biol Chem       Date:  2020-03-09       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.